Jackson Creek Investment Advisors’s Haemonetics HAE Stock Holding History

Jackson Creek Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,293	Closed	-$934K	–	323
2024 Q2	$934K	Sell	11,293 -78	-0.7%	-$6.86K	0.34%	168
2024 Q1	$971K	Sell	11,371 -108	-0.9%	-$8.48K	0.35%	168
2023 Q4	$982K	Sell	11,479 -12	-0.1%	-$1.04K	0.38%	128
2023 Q3	$1.03M	Sell	11,491 -64	-0.6%	-$5.71K	0.43%	62
2023 Q2	$984K	Sell	11,555 -2,581	-18%	-$218K	0.39%	93
2023 Q1	$1.17M	Buy	14,136 +1,506	+12%	+$122K	0.49%	24
2022 Q4	$993K	Sell	12,630 -449	-3%	-$36.1K	0.44%	51
2022 Q3	$968K	Buy	+13,079	New	+$939K	0.45%	48

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Jackson Creek Investment Advisors's HAE Position: Q3 2024 in Review

Jackson Creek Investment Advisors sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 11,293 shares — an estimated $934K sold.

Jackson Creek Investment Advisors first reported a position in HAE in Q3 2022 and held it in 8 quarters. The position peaked at $1.17M in Q1 2023. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

Jackson Creek Investment Advisors reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
Jackson Creek Investment Advisors sold 11,293 Haemonetics shares in Q3 2024, an estimated $934K.
Jackson Creek Investment Advisors first reported a position in Haemonetics in Q3 2022 and held it in 8 quarters.
Jackson Creek Investment Advisors's Haemonetics position peaked at $1.17M in Q1 2023.
306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Jackson Creek Investment Advisors's 13F filing for Q3 2024, filed 4 Nov 2024.